Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: Final results of a randomized multi-institutional trial

被引:0
|
作者
Ryuichiro Doi
Masayuki Imamura
Ryo Hosotani
Toshihide Imaizumi
Takashi Hatori
Ken Takasaki
Akihiro Funakoshi
Hideyuki Wakasugi
Takehide Asano
Shoichi Hishinuma
Yoshiro Ogata
Makoto Sunamura
Koji Yamaguchi
Masao Tanaka
Sonshin Takao
Takashi Aikou
Koichi Hirata
Hiroyuki Maguchi
Koichi Aiura
Tatsuya Aoki
Akira Kakita
Makoto Sasaki
Masahiko Ozaki
Satoru Matsusue
Shunichi Higashide
Hideki Noda
Seiyo Ikeda
Shunzo Maetani
Shigeaki Yoshida
机构
[1] Kyoto University,Department of Surgery
[2] Tokyo Women’s Medical University,Department of Gastroenterological Surgery
[3] National Kyushu Cancer Center,Department of Gastroenterology
[4] Chiba University,Second Department of Surgery
[5] Tochigi Cancer Center,Department of Surgery
[6] Tohoku University School of Medicine,First Department of Surgery
[7] Kyushu University,Department of Surgery and Oncology
[8] Kagoshima University,Department of Surgical Oncology and Digestive Surgery
[9] Sapporo Medical University,First Department of Surgery
[10] Teine Keijinkai Hospital,Center for Gastroenterology
[11] Keio University,Department of Surgery
[12] Tokyo Medical College,Department of Surgery
[13] Kitasato University,Department of Surgery
[14] National Nagasaki Medical Center,Department of Surgery
[15] Yokohama Rousai Hospital,Department of General Surgery
[16] Tenri Hospital,Department of Abdominal Surgery
[17] Nagahama City Hospital,Department of Surgery
[18] Fukuoka University,First Department of Surgery
[19] Tenri Institute of Medical Research,undefined
[20] National Cancer Center Hospital East,undefined
来源
Surgery Today | 2008年 / 38卷
关键词
Pancreatic cancer; Local invasion; Radiochemotherapy; Randomized multi-institutional trial; Laparotomy; Long-term survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1021 / 1028
页数:7
相关论文
共 50 条
  • [41] Predictors of retained hemothorax in trauma: Results of an Eastern Association for the Surgery of Trauma multi-institutional trial
    Prakash, Priya S.
    Moore, Sarah A.
    Rezende-Neto, Joao B.
    Trpcic, Sandy
    Dunn, Julie A.
    Smoot, Brittany
    Jenkins, Donald H.
    Cardenas, Tatiana
    Mukherjee, Kaushik
    Farnsworth, Joshua
    Wild, Jeffrey
    Young, Katelyn
    Schroeppel, Thomas J.
    Coimbra, Raul
    Lee, Jeanne
    Skarupa, David J.
    Sabra, Michel J.
    Carrick, Matthew M.
    Moore, Forrest O.
    Ward, Jeanette
    Geng, Thomas
    Lapham, David
    Piccinini, Alice
    Inaba, Kenji
    Dodgion, Christopher
    Gooley, Brian
    Schwartz, Tim
    Shraga, Sarrina
    Haan, James M.
    Lightwine, Kelly
    Burris, Jennifer
    Agrawal, Vaidehi
    Seamon, Mark J.
    Cannon, Jeremy W.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2020, 89 (04): : 679 - 685
  • [42] Advantages of minimally invasive surgery for remnant gastric cancer: A multi-institutional cohort study.
    Aoyama, Ryuhei
    Tsunoda, Shigeru
    Okamura, Ryosuke
    Yamashita, Yoshito
    Hata, Hiroaki
    Kinjo, Yousuke
    Miki, Akira
    Kanaya, Seiichiro
    Yamamoto, Michihiro
    Matsuo, Koichi
    Manaka, Dai
    Itami, Atsushi
    Kan, Takatsugu
    Ito, Tetsuo
    Hirai, Kenjiro
    Hosogi, Hisahiro
    Nishigori, Tatsuto
    Hisamori, Shigeo
    Hoshino, Nobuaki
    Obama, Kazutaka
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 357 - 357
  • [43] Imperative versus elective minimally-invasive partial nephrectomy: Results of a multi-institutional collaborative series
    Anceschi, U.
    Flammia, R. S.
    Brassetti, A.
    Tuderti, G.
    Ferriero, M. C.
    Minervini, A.
    Mari, A.
    Grosso, A.
    Carini, M.
    Capitanio, U.
    Larcher, A.
    Montorsi, F.
    Autorino, R.
    Veccia, A.
    Fiori, C.
    Amparore, D.
    Porpiglia, F.
    Eun, D.
    Lee, J.
    Deerwesh, I.
    Sundaram, C.
    Steward, J.
    Gallucci, M.
    Simone, G.
    EUROPEAN UROLOGY, 2021, 79 : S780 - S781
  • [44] Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC-1): A randomized, controlled, multicenter phase III trial.
    Van Tienhoven, Geertjan
    Versteijne, Eva
    Suker, Mustafa
    Groothuis, Karin B. C.
    Busch, Olivier R.
    Bonsing, Bert A.
    de Hingh, Ignace H. J. T.
    Festen, Sebastiaan
    Patijn, Gijs A.
    de Vos-Geelen, Judith
    Zwinderman, Aeilko H.
    Punt, Cornelis J. A.
    van Eijck, Casper H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18)
  • [45] A Multi-Institutional Phase 2 Trial of Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided On-Table Adaptive Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
    Parikh, Parag Jitendra
    Lee, Percy
    Low, Daniel A.
    Kim, Joshua
    Mittauer, Kathryn E.
    Bassetti, Michael F.
    Glide-Hurst, Carri K.
    Raldow, Ann C.
    Yang, Yingli
    Portelance, Lorraine
    Padgett, Kyle R.
    Zaki, Bassem
    Zhang, Rongxiao
    Kim, Hyun
    Henke, Lauren E.
    Price, Alex T.
    Mancias, Joseph D.
    Williams, Christopher L.
    Ng, John
    Pennell, Ryan
    Pfeffer, M. Raphael
    Levin, Daphne
    Mueller, Adam C.
    Mooney, Karen E.
    Kelly, Patrick
    Shah, Amish P.
    Boldrini, Luca
    Placidi, Lorenzo
    Fuss, Martin
    Chuong, Michael D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (04): : 799 - 808
  • [46] A multi-institutional, single-arm, phase II trial of neoadjuvant modified-FOLFIRINOX for resectable pancreatic ductal adenocarcinoma
    Lee, Choong-kun
    Hwang, Ho Kyoung
    Jeung, Hei-Cheul
    Chon, Hongjae
    Park, Hyung Soon
    Kim, Min Hwan
    Park, Mi-Suk
    Kang, Chang Moo
    Choi, Hye Jin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [47] Similar Outcomes in Minimally Invasive Versus Open Management of Pancreatic Neuroendocrine Tumors: A Multi-Institutional Collaborative Analysis
    Sutton, T.
    Worth, P.
    Pommier, R.
    Mayo, S.
    Gilbert, E.
    Papavasiliou, P.
    Babicky, M.
    Gerry, J.
    Sheppard, B. C.
    PANCREAS, 2021, 50 (07) : 1100 - 1101
  • [48] A multi-institutional phase II trial of preoperative full dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma
    Talamonti, MS
    Small, W
    Mulcahy, MF
    Attaluri, V
    Colletti, L
    Zalupski, MM
    Hoffman, J
    Freedman, GM
    Kinsella, TJ
    McGinn, CJ
    ANNALS OF SURGICAL ONCOLOGY, 2005, 12 (02) : S13 - S13
  • [49] ESPAC-1:: final results of a European, randomized controlled trial to assess the roles of adjuvant chemotherapy and adjuvant chemoradiation in resectable pancreatic cancer
    Stocken, DD
    Neoptolemos, JP
    Friess, H
    Bassi, C
    Dunn, JA
    Hickey, H
    Imrie, C
    Deakin, M
    Buckels, J
    Dervenis, C
    Oláh, A
    Fernandez-Cruz, L
    Lacaine, F
    Büchler, MW
    BRITISH JOURNAL OF SURGERY, 2004, 91 (04) : 520 - 520
  • [50] Taxane-based chemoirradiation for organ preservation with locally advanced head and neck cancer: Results of a phase II multi-institutional trial
    Cmelak, Anthony J.
    Murphy, Barbara A.
    Burkey, Brian
    Douglas, Stacy
    Shyr, Yu
    Netterville, James
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (04): : 315 - 324